Hematologic Malignancies Testing Market Valued at $6.92 Billion in 2024, Set for Strong Growth - SRI

AI Briefing

• – Global Hematologic Malignancies Testing Market projected to reach $14.1 billion by 2030, with a CAGR of 7.5% from 2026 to 2030.
• – Increasing adoption of next-generation sequencing and advanced diagnostics driving growth in the market.
• – Key players like Foundation Medicine and Guardant Health are leading the charge in developing innovative testing solutions.